PubMed COVID-19 Clinical Care

Increasing evidence highlights that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has long-term effects on cognitive function, which may cause neurodegenerative diseases like Alzheimer's disease (AD) in the future. We

By using three continuous years of national-scale cellphone signaling data from Jan. 2019 to Dec. 2021, this study adds fresh evidence for job-housing balance changes at the Quxian level during the COVID-19 period in China. The findings show that

CONCLUSIONS: TSPO-PET can be a valuable tool in the diagnostic and therapeutic monitoring of COVID-19-related encephalitis, particularly in cases where MRI scans are negative. Aggressive immunosuppressive therapy can lead to sustained remission.

CONCLUSIONS: Contrary to expectations, non-mask wearing subjects touched their face more frequently than those who were wearing a mask. This is significant because wearing a face mask had a negative association with face touching. When wearing a mask

CONCLUSIONS: Overall, the epidemic wave in rural China peaked between December 20-22, 2022, and passed quickly following the optimization of prevention and control measures. Currently, SARS-CoV-2 infection in community populations in rural China is

CONCLUSIONS: We implemented and evaluated a telehealth consultation and collaborative care service between AS providers at multiple centres. AHS has since prioritized similar workflows, including access to specialists in acute care, as part of their

CONCLUSION: Patients and clinicians viewed telemedicine favorably as an alternative to face-to-face clinics during the pandemic and included studies did not identify any safety concerns. Its role post-pandemic is not clearly defined, although these

CONCLUSION: The findings illustrate that educational interventions improved COVID-19 and vaccine knowledge among patients and that the knowledge was retained. Educational interventions serve as powerful tools to increase knowledge within communities

In this work, HKUST-1 and Cu-BDC nanoparticles were used as delivery systems for the early anti-COVID-19 drug, hydroxychloroquine. The antiviral MOF/drug combinations significantly reduced the infectivity of SARS-CoV-2, which can be attributed to the

The 2020 year-end holidays were a time of much apprehension regarding COVID-19, with U.S. health officials concerned that travel would result in a post-holiday surge of the disease. As such, much effort was expended encouraging people to forego their